Donna J. Barry, MSN, MPH
Donna J. Barry is the Executive Director of Global Oncology. She is the first person to hold this position. Global Oncology (GO) is a nonprofit organization with a mission to help reduce disparities in access to cancer care around the world. Most recently, Donna Barry served as the Director of Women’s Health and Rights at the Center for American Progress (CAP) from 2013-2015. In this role, she led the CAP policy team to develop progressive policy to improve women’s access to health care, with a focus on reproductive health care. Previously Donna was the Advocacy and Policy Director at Partners In Health (PIH) where she began working in 2001. She led the PIH project to treat multi-drug resistant tuberculosis in Russia and was Co-Director of PIH’s women’s health programs in Haiti. She guided PIH’s advocacy and policy efforts related to health and hunger, socio-economic development in Haiti, increasing the pool of funding for global health and health system strengthening. Donna participated in briefings and hearings on Capitol Hill regarding reproductive health, debt relief in Haiti, childhood malnutrition, tuberculosis, and funding for global health. A Nurse Practitioner with certification in women’s health, Donna also supported PIH’s nursing activities and provided clinical and program advice to PIH’s women’s health programs.
She earned degrees in Political Science and Russian at Saint Louis University, and then went on to Columbia University in New York, where she earned Masters’ Degrees in International Affairs and Public Health. She completed her RN and Masters of Science in Nursing at the MGH Institute of Health Professions.
Board of Directors
Ami is an Assistant Professor of Medicine and Genetics and Director for Global Oncology (Center for Innovation in Global Health) at Stanford University. She is the co-founder and co-director of Global Oncology, Inc, a federally incorporated non-profit organization focused on harnessing creativity, volunteerism and international collaborators to solve challenging problems related to cancer and palliative care inequity. In addition to her global oncology-related work, Ami is the Principle Investigator of a research laboratory that studies the relationship between the microbiome and morbidity/mortality in cancer patients.
Franklin is an Instructor in Medicine at Harvard Medical School and Dana-Farber Cancer Institute in Boston, Massachusetts. He is a postdoctoral scholar at the Broad Institute. He received his M.D. at Washington University School of Medicine in St. Louis and his Ph.D. in genetics at Harvard University. He completed his residency in internal medicine at the Massachusetts General Hospital followed by a fellowship in hematology and medical oncology at the Dana-Farber/PartnersCancerCare Program. Dr. Huang is working to improve cancer treatment in underserved and understudied populations. His research focuses on prostate cancer and on the role of non-coding mutations in cancer. Dr. Huang has also worked in global health for over ten years and along with Ami Bhatt, is the co-founder and co-director of Global Oncology (GO), a volunteer non-profit organization dedicated to improving cancer care and research in the developing world.
George Bickerstaff is an internationally recognized expert in finance, healthcare and philanthropy. He is an active investor and contributes significant time and energy to helping disadvantage children through philanthropic activities.
George has founded companies in the financial services, healthcare and information technology industries and has held senior executive and board positions in some of the largest and most respected companies in the world.
George is currently Managing Director of M.M. Dillon, an investment bank and private equity firm which he co-founded. Prior to joining M.M. Dillon, George was the Chief Financial Officer of Novartis Pharma AG, one of the largest pharmaceutical companies in the world. Previously, George was the Chief Financial Officer of IMS Healthcare and a senior executive of Dun & Bradstreet. George began his earlier career in finance and engineering with General Electric.
George is a frequent lecturer and quest speaker on finance, leadership and philanthropy and gained a global perspective by living and working in Asia, Europe, Latin America, and the United States.
George holds business and engineering degrees from Rutgers University and continued his executive education at Harvard Business School.
- Finance, Healthcare, Philanthropy
- Strategic, Business and Financial Planning
- Public Health and Public / Private Partnerships
- Information Technology and Business Networks
- Board, Leadership and Management Development
- Audit, Corporate Governance and Internal Controls
- Capital Markets, Hedge Funds, Private Equity, and Venture Capital
- Biotechnology, Diabetes, Pharmaceuticals, Oncology, and Vaccines
Michele joined Shire in April, 2015, as Senior Vice President and Head, Communications & Public Affairs, reporting to CEO Flemming Ornskov, and serving as an extended member of the Shire Executive Committee.
A lawyer and journalist, Michele most recently served as a Managing Director for MPM Capital and as a communication advisor and executive coach to corporate and global health clients. Michele earlier spent 14 years at Novartis in global leadership roles, including as Chief Communications Officer reporting to the CEO and residing in Basel, Switzerland. She also led diverse externally facing global functions and served as a member of management for Novartis Global Oncology and for the Novartis Pharmaceuticals Division.
Michele worked as Managing Director for Burson-Marsteller, where she co-founded the Organizational Effectiveness Practice; Legal Affairs and Social Issues Editor for Business Week; and as an associate for Skadden, Arps, Slate, Meagher & Flom.
Michele has a BA from George Washington University, JD from New York University School of Law, and MS in Journalism from Columbia University. She is member of the board of Global Oncology, a non-profit dedicated to enhancing global cancer care and treatment, and has served on the boards of the Global Health Council and nonprofit StupidCancer.
Amy Judd joined the Brigham and Women’s Hospital (BWH) Division of Global Health Equity (DGHE) in 2003, shortly after the Division was launched by Paul Farmer, Jim Yong Kim and Howard Hiatt. As DGHE’s Director of Program Development, Amy managed the implementation of global health initiatives, including: MDR-TB training and research programs in Russia; the BWH residency in Internal Medicine and Global Health Equity; and, a major collaboration between BWH clinical faculty, the Indian Health Service and Navajo Nation.
Her current focus is on improving access to cancer care in low resource settings and mentoring students, trainees and young professionals working in global health. She served as a technical advisor on the Global Task Force on Cancer Care and Control and the Harvard Global Equity Initiative, and on the Global Oncology steering committee. Earlier in her career she held senior staff positions at Massachusetts General Hospital and Yale-New Haven Hospital.
Amy has a BS from Cornell University and an MS from the Harvard School of Public Health.